4.5 Article

The significance of low DBP in US adults with isolated systolic hypertension

期刊

JOURNAL OF HYPERTENSION
卷 29, 期 6, 页码 1101-1108

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/HJH.0b013e328346a599

关键词

cardiovascular disease; epidemiology; hypertension; population science; risk factors

资金

  1. Forest Research Laboratories
  2. Forest Research Laboratories through the University of California
  3. Novartis Pharmaceuticals
  4. Bristol Myers-Squibb

向作者/读者索取更多资源

Objectives To determine the features of isolated systolic hypertension (ISH), the most common hypertensive subtype in persons at least age 50, associated with greater cardiovascular disease (CVD) risk when accompanied by low diastolic blood pressure (DBP). Design Data were obtained from adult hypertensives at least age 18 in the National Health Nutrition Examination Survey (NHANES) 1999-2006 (n=19 808, projected to 199.3 million). Method ISH were categorized by low DBP (<70mmHg) vs. higher DBP (>= 70-89 mmHg), treatment status, age, sex, ethnicity, cardiometabolic risk factors, and comorbidities. Results A 58.6% of all untreated US hypertensives had ISH (mean blood pressure 154.3/73.8 mmHg). Untreated and treated persons with ISH and DBP less than 70mmHg represented 30 and 35%, respectively, of the ISH population and had almost twice the prevalence of diabetes and CVD, but a lower prevalence of the metabolic syndrome (P<0.05 to P<0.01). There was a three-fold greater prevalence of CVD from the highest to the lowest DBP strata in untreated ISH (P<0.01). Logistic regression showed that age, female sex, and diabetes, but not treatment status, were independently associated with lower DBP (all P<0.01). Of those persons with ISH and DBP less than 70 mmHg, 45% remain untreated. Conclusion Older persons with untreated ISH and DBP less than 70mmHg, comprising almost one-third of the untreated ISH population, had greater prevalence of diabetes and CVD than persons with ISH in association with DBP 70-89mmHg. Intensified efforts to identify and adequately treat these individuals are needed to reduce their associated CVD risk. J Hypertens 29: 1101-1108 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据